ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Mergers & Acquisitions

Amgen to acquire Denmark’s Nuevolution

by Michael McCoy
May 25, 2019 | APPEARED IN VOLUME 97, ISSUE 21

 

Amgen plans to pay about $167 million to acquire Nuevolution, a Danish firm that invented a DNA-encoded library method for small-molecule drug discovery. Amgen and Nuevolution have been partners since October 2016 in a discovery pact that they say has yielded two promising cancer programs. Amgen research chief Raymond Deshaies says the deal will “significantly expand Amgen’s ability to discover novel small molecules against difficult-to-drug targets.”

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment